Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT00516724Phase 1Completed
Study to Assess the Safety and Tolerability of a PARP Inhibitor in Combination With Carboplatin and/or Paclitaxel
Advanced Ovarian CancerCarboplatinPaclitaxel+1 more
PrincipalinvestigatorStart date: 2007-06-22

Research Network

Collaboration Network

15 collaborators·15 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Cancer Research UK, The Institute of Cancer Research, London, UK

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Jane Robertson, BSc, MBCHB, MD

AstraZeneca

Moderately Similar
12 trials

Shared therapeutic areas:

Advanced Ovarian CancerCarboplatinPaclitaxel+1 more

Worked with same sponsors:

AstraZeneca
Collaborated on 1 trial
Similarity Score44%

Prof Jan HM Schellens

The Netherlands Cancer Institute, Amsterdam, The Netherlands

Moderately Similar
1 trials

Shared therapeutic areas:

Advanced Ovarian CancerCarboplatinPaclitaxel+1 more

Worked with same sponsors:

AstraZeneca
Collaborated on 1 trial
Similarity Score44%

Irtiza N Sheikh, MD

M.D. Anderson Cancer Center

Related
1 trials

Shared therapeutic areas:

Carboplatin
Similarity Score8%

Giorgio Senaldi, MD, PhD

Daiichi Sankyo

Related
1 trials

Shared therapeutic areas:

Advanced Ovarian Cancer
Similarity Score8%

Manal H El Hamamsy, Doctorate

Ain Shams University - Faculty of Pharmacy

Related
1 trials

Shared therapeutic areas:

Paclitaxel
Similarity Score8%

Prof Paul DiSilvestro, MD

Women & Infants Hospital, Providence, Rhode Island, USA

Related
1 trials

Shared therapeutic areas:

Advanced Ovarian Cancer

Worked with same sponsors:

AstraZeneca
Similarity Score8%

Sahar Salehi, MD, PhD

Karolinska Institute and Karolinska University Hospital

Related
1 trials

Shared therapeutic areas:

Advanced Ovarian Cancer
Similarity Score8%

Feilin Cao, MD

Zhejiang Taizhou hospital

Related
1 trials

Shared therapeutic areas:

Paclitaxel
Similarity Score8%

Philipp Harter

European Network of Gynaecological Oncological Trial Groups (ENGOT)

Related
1 trials

Shared therapeutic areas:

Advanced Ovarian Cancer

Worked with same sponsors:

AstraZeneca
Similarity Score8%

hisham abo taleb, lecturer

Assiut University

Related
1 trials

Shared therapeutic areas:

Advanced Ovarian Cancer
Similarity Score8%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT00516724Phase 1PrincipalInvestigator

Study to Assess the Safety and Tolerability of a PARP Inhibitor in Combination With Carboplatin and/or Paclitaxel

Advanced Ovarian CancerCarboplatinPaclitaxel+1 more
Completed

All 1 trials loaded